Metoprolol Succinate Tablet, Extended Release
Product Images NDC 70518-2080

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 70518-2080). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Label for Metoprolol Succinate extended-release tablets, 100 mg strength. The package contains 90 tablets. The product is labeled RX only with NDC 70518-2080-01 and is repackaged by RemedyRepack Inc. in Indiana. Manufacturer is Dr. Reddy's Labs, India. Storage instructions indicate 20-25°C with permitted excursions.*
FDA Label Image

Figure

Figure
A forest plot chart titled 'Results for Subgroups in MERIT-HF,' showing relative risk and 95% confidence intervals for total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure across multiple patient subgroups. Subgroups include geographic region, NYHA class, ejection fraction, ischemic etiology, sex, race, prior myocardial infarction, diabetes, hypertension, and heart rate. The chart visually compares the favorability of metoprolol succinate extended-release tablets versus placebo in these outcomes.*
FDA Label Image

Structure

Structure
Chemical structure of Metoprolol succinate, showing its molecular components and arrangement as part of the active ingredient in the drug Metoprolol succinate extended-release tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.